focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Korean Market Trial

30 Mar 2009 07:00

RNS Number : 6770P
Phorm Inc
30 March 2009
 



Phorm, Inc. ('Phorm' or 'the Company')

Korean Market Trial

Phorm (AIM:PHRM and PHRX), the advertising technology company, today announces that it is beginning a market trial with leading Korean internet service provider (ISP) KT. 

According to the Organisation for Economic Co-operation and Development (OECD), Korea has approximately 15 million broadband customers, making it the sixth largest broadband market in the world. Furthermore, with household penetration of around 90%, Korea has higher broadband take-up than markets including the UK, the US and Japan. Zenith Optimedia estimates that Korea's online advertising market was worth $1.6 billion (15.5% of total domestic marketing spend) in 2008, making it the seventh largest market globally. KT is the leading ISP in Korea with an estimated market share of 44%. 

The Company also announces the appointment of Daniel Park as CEO of Phorm Korea and the opening of its office in Seoul. An established and well-known industry figure, Daniel joins Phorm from SK Communications, Korea's second largest internet portal, where he was Senior Vice President of the Search and Portal Division. 

In addition to its accelerating activity in Asia, Phorm has already signed exclusive agreements with the UK's three leading ISPs, BT, TalkTalk and Virgin Media, and is also very encouraged by discussions which it is having with other global ISPs. Furthermore, the commercial potential and high levels of user privacy protection provided by Phorm's technology have recently been recognised by UK regulatory bodies such as OfcomThe Department for Business, Enterprise & Regulatory Reform (BERR) and the Information Commissioner's Office.

Kent Ertugrul, Founder and Chief Executive of Phorm, commented: "Just as KT has led the way in helping to create one of the world's leading online societies, we believe that today's announcement will put Korea at the forefront of a new revenue model for the Internet which creates exciting opportunities for all concerned. This system promises to boost the value chain that connects consumers, content creators and advertisers. We also believe that this technology offers a new model for online privacy by demonstrating how users can browse in complete anonymity, with no storage of browsing history while showing offers which they find useful."

  

Enquiries: 

Phorm, Inc

Sarah Simon

+44 20 7297 2433

Maria Greenwood

+44 20 7297 2537

 

Citigate Dewe Rogerson

+44 20 7638 9571 

Simon Rigby

Justin Griffiths 

 

Canaccord Adams Limited

+44 20 7050 6500 

(Nominated Adviser)

Mark Williams

Andrew Chubb

About Phorm:

Phorm is an innovative advertising technology company specialising in interest-based advertising which preserves users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers. 

Phorm is a Delaware, US incorporated company, with offices in New York and London. 

The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees. 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWUUGAWUPBUAU
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.